| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/05/2007 | US7226992 proteins of the present invention can be used in biological assays to identify substances which block the ability of Bcl-2 to inhibit programmed cell death |
| 06/05/2007 | US7226990 Extendin derivatives |
| 06/05/2007 | US7226909 Methods of inhibiting transmission of a costimulatory signal of lymphocytes |
| 06/05/2007 | US7226770 For use in detergents and in baking |
| 06/05/2007 | US7226758 glial derived neurotrophic factor (GDNF) isolated from serum-free growth conditioned medium of glioblastoma cells; for preventing and treating nerve damage and nerve related diseases such as Parkinson's disease; genetic engineering |
| 06/05/2007 | US7226749 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84 |
| 06/05/2007 | US7226741 Multimerization of HIV-1 Vif protein as a therapeutic target |
| 06/05/2007 | US7226604 Chemically inactivated EHV-1 KyA virus; and an adjuvant which includes cross-linked olefinically unsaturated carboxylic acid polymer |
| 06/05/2007 | US7226601 binds to both the T cell receptor and an MHC class II antigen; superantigen peptide and affinity counterpart are covalently linked; conjugates have the ability to activate and direct T-lymphocytes |
| 06/05/2007 | US7226596 Metalloenzymes; antiproliferative agents; anticarcinogenic agents; cancer diagnosis; antisense agents; complementary determining regions |
| 06/05/2007 | US7226595 Conjugated antigen for use as tool in the treatment of cancer |
| 06/05/2007 | US7226594 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
| 06/05/2007 | US7226593 Methods of treating cachexia with chimeric anti-TNF antibodies |
| 06/05/2007 | US7226592 different epitopes are located within the binding domain of the natural ligand(s) of said receptor; first and second antigen-binding site binds to a different epitope on the same EGFR molecule |
| 06/05/2007 | US7226591 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis |
| 06/05/2007 | CA2394018C Bzip transcription factor that controls expression of the storage protein in the rice plant |
| 06/05/2007 | CA2332310C Antibody against protein tyrosine phosphatase intracellular domains |
| 06/05/2007 | CA2273823C Polypeptides encoded by a human lipase-like gene, compositions and methods |
| 06/05/2007 | CA2143442C Dorsal tissue affecting factor and compositions |
| 05/31/2007 | WO2007062359A1 Methods and reagents for elimination or reduction of false positives in the analysis of a sample |
| 05/31/2007 | WO2007062245A2 Human monoclonal antibody human cd134 (ox40) and methods of making and using same |
| 05/31/2007 | WO2007062101A2 Intraocular pressure-regulated early genes and uses thereof |
| 05/31/2007 | WO2007062037A2 Compositions and methods of producing hybrid antigen binding molecules and uses thereof |
| 05/31/2007 | WO2007061936A2 Clearance of abnormal iga1 in iga1 deposition diseases |
| 05/31/2007 | WO2007061679A1 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH α4β7 INTEGRIN |
| 05/31/2007 | WO2007061292A1 Uses of the fcrn receptor |
| 05/31/2007 | WO2007061281A2 Prevention and treatment of porcine reproductive and respiratory syndrome (prrs) |
| 05/31/2007 | WO2007060899A1 Application of actin-binding protein to disease associated with cell motility |
| 05/31/2007 | WO2007060425A1 Thrombospondin domain-containing cell surface recognition molecules |
| 05/31/2007 | WO2007060423A1 Signal anchored protein |
| 05/31/2007 | WO2007060411A1 Anti-tnf alpha antibodies which selectively inhibit tnf alpha signalling through the p55r |
| 05/31/2007 | WO2007059997A1 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 05/31/2007 | WO2007059782A1 Recombinant monovalent antibodies and methods for production thereof |
| 05/31/2007 | WO2007059715A2 Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses |
| 05/31/2007 | WO2007059612A1 Novel stem cells, nucleotide sequences and proteins therefrom |
| 05/31/2007 | WO2007059574A1 A molecule and chimeric molecules thereof |
| 05/31/2007 | WO2007042524A3 Treating diabetes using inhibitors of il-1 |
| 05/31/2007 | WO2007037560A9 Therapeutic or diagnostic application of sgk2 gene |
| 05/31/2007 | WO2007037555A9 Therapeutic or diagnostic application of dusp15 gene |
| 05/31/2007 | WO2007037550A9 Therapeutic or diagnostic application of tsta3 gene |
| 05/31/2007 | WO2007037538A9 Therapeutic or diagnostic application of spo11 gene |
| 05/31/2007 | WO2007037533A9 Therapeutic or diagnostic application of ppp1r3d gene |
| 05/31/2007 | WO2007037532A9 Therapeutic or diagnostic application of srms gene |
| 05/31/2007 | WO2007025276A3 Use of hiv envelope/ cd4 complexes as immunogenic complexes for the generation of antibodies |
| 05/31/2007 | WO2007023298A3 Antibodies |
| 05/31/2007 | WO2007007145A3 Use of anti-madcam antibodies for the treatment of coeliac disease and tropical sprue |
| 05/31/2007 | WO2006122046A3 Vascular disease therapies |
| 05/31/2007 | WO2006120019A3 Mcm9, a member of the mcm2-8 family and its use in pharmaceutical compositions |
| 05/31/2007 | WO2006118772A3 Fcrn antibodies and uses thereof |
| 05/31/2007 | WO2006110496A3 Activation of sodium potassium atpase |
| 05/31/2007 | WO2006102200A3 Docetaxel immunoassay |
| 05/31/2007 | WO2006098987A3 Methods of inhibiting angiogenesis and tumor development |
| 05/31/2007 | WO2006004593A3 Method for preventing and treating mast cell mediated diseases |
| 05/31/2007 | WO2005117970A3 Antibodies of angiogenesis inhibiting domains of cd148 |
| 05/31/2007 | WO2005094338A3 Treatment of type 1 diabetes with inhibitors of macrophage migration inhibitory factor |
| 05/31/2007 | WO2005017484A3 Methods for identifying compounds for regulating muscle mass or function using dopamine receptors |
| 05/31/2007 | WO2004100882A3 Inhibition of drug binding to serum albumin |
| 05/31/2007 | US20070123699 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 05/31/2007 | US20070123696 G-csf conjugates |
| 05/31/2007 | US20070123479 single chain antibody construct comprising binding domains specific for human CD3 and human CD19; anticarcinogenic biodrug for treating non-Hodgkin lymphoma |
| 05/31/2007 | US20070123466 Method of treating recurrent miscarriages |
| 05/31/2007 | US20070123459 IL-17 like molecules and uses thereof |
| 05/31/2007 | US20070122883 Nucleotide sequences coding orphan receptor component of multimeric complex for use in identifying modulator for prevention and treatment of cell proliferative disorders |
| 05/31/2007 | US20070122882 Gene specifically expressed in postmitotic dopaminergic neuron precursor cells |
| 05/31/2007 | US20070122879 for detecting and treating viral infections in in vitro and in vivo; ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo; for forming a heterodimeric receptor complex with IL-28R and CRF2-4 |
| 05/31/2007 | US20070122859 Immunoassay for LSD and 2-oxo-3-hydroxy-LSD |
| 05/31/2007 | US20070122857 BepA protein specific immunoglobulin for diagnosing/prognosing proteobacterium infection |
| 05/31/2007 | US20070122853 Methods and compositions for detecting larval Taenia solium with a cloned diagnostic antigen |
| 05/31/2007 | US20070122852 Method for identifying antigen specific b cells |
| 05/31/2007 | US20070122846 Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
| 05/31/2007 | US20070122810 Brain tumor marker and method of diagnosing brain tumor |
| 05/31/2007 | US20070122803 Methods for the detection of polymorphisms in the human oatpf gene |
| 05/31/2007 | US20070122801 Binding molecules capable of neutralizing west nile virus and uses thereof |
| 05/31/2007 | US20070122422 Sodium-independent small neutral amino acid transporter transporting L- and D- amino acids |
| 05/31/2007 | US20070122416 Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use |
| 05/31/2007 | US20070122415 Compound and method for suppressing retroviral replication |
| 05/31/2007 | US20070122413 Il-21 antagonists |
| 05/31/2007 | US20070122412 Eg-vegf nucleic acids and polypeptides and methods of use |
| 05/31/2007 | US20070122411 Solid forms of anti-egfr antibodies |
| 05/31/2007 | US20070122410 Use of an active substance binding to CD28 for producing a pharmaceutical composition for the treatment of B-CLL |
| 05/31/2007 | US20070122409 Compounds, Compositions and Methods for the Endocytic Presentation of Immunosuppressive Factors |
| 05/31/2007 | US20070122408 Fc Labeling for Immunostaining and Immunotargeting |
| 05/31/2007 | US20070122407 ISOLATED NUCLEIC ACIDS, VECTORS AND HOST CELLS ENCODING ErbB3 ANTIBODIES |
| 05/31/2007 | US20070122406 Humanized Epithelial cell adhesion molecule (Ep-CAM) antibodies; cytotoxic chemotherapeutics; antitumor agents |
| 05/31/2007 | US20070122405 Human G-protein chemokine receptor (CCR5) HDGNR10 |
| 05/31/2007 | US20070122404 Humanized immunoglobulin reactive with alpha4beta7 integrin |
| 05/31/2007 | US20070122403 Molecules with extended half-lives, compositions and uses thereof |
| 05/31/2007 | US20070122382 Methods of treating cancer using il-21 and monoclonal antibody therapy |
| 05/31/2007 | CA2631184A1 Recombinant monovalent antibodies and methods for production thereof |
| 05/31/2007 | CA2631015A1 Human monoclonal antibody human cd134 (ox40) and methods of making and using same |
| 05/31/2007 | CA2630668A1 Intraocular pressure-regulated early genes and uses thereof |
| 05/31/2007 | CA2630629A1 Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses |
| 05/31/2007 | CA2630283A1 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use |
| 05/31/2007 | CA2629147A1 Humanized immunoglobulin reactive with .alpha.4.beta.7 integrin |
| 05/31/2007 | CA2628530A1 Novel stem cells, nucleotide sequences and proteins therefrom |
| 05/31/2007 | CA2628126A1 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 05/31/2007 | CA2627446A1 Compositions and methods of producing hybrid antigen binding molecules and uses thereof |
| 05/30/2007 | EP1790730A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/30/2007 | EP1790729A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/30/2007 | EP1790728A2 Imaging, diagnosis and treatment of disease |